Karin Weber

Karin Weber

Auto-generated profile, based on publicly available information

Karin Weber

Clinic of Small Animal Medicine, LMU University of Munich, Munich, Germany

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2003 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
UZUte Zeitz
Ute Zeitz
KWKarin Weber
Karin Weber
DSDesi W. Soegiarto
Desi W. Soegiarto
EWEckhard Wolf
Eckhard Wolf
RBRudi Balling
Rudi Balling
REReinhold G. Erben
Reinhold G. Erben
It was the aim of this study to further explore the functional role of vitamin D in the endocrine pancreas. By gene targeting, we have recently generated mice in which a lacZ reporter gene is driven by the endogenous vitamin D receptor (VDR) promoter. These mice express a functionally inactive mutant VDR. Pancreatic islets but not exocrine pancreas cells showed strong lacZ reporter gene expression in mutant mice. To rule out possible influences of hypocalcemia on pancreatic endocrine function, a rescue diet enriched with calcium, phosphorus, and lactose was fed to wild‐type (WT) and VDR mutant mice. The rescue diet normalized body weight and mineral homeostasis in VDR mutants. In glucose tolerance tests, baseline blood glucose levels were unchanged in fasting VDR mutants. However, blood glucose was elevated after oral or subcutaneous glucose loading, and maximum serum insulin levels were reduced by ~60% in VDR mutants vs. WT mice on either diet. In addition, insulin mRNA levels were decreased in VDR mutant mice on both diets, whereas pancreatic β cell mass, islet architecture, and islet neogenesis were normal. These findings clearly establish a molecular role of the VDR in pancreatic insulin synthesis and secretion in vivo.

1 December 2001 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
KWKarin Webera
Karin Webera
REReinhold G. Erben
Reinhold G. Erben
ARAndreas Rump
Andreas Rump
Jerzy AdamskiJerzy Adamski
Jerzy Adamski

1 September 2014 in The Veterinary Journal
Verified
Journal Article
Closed access
BSBianka Schulz
Bianka Schulz
SKS. Kurz
S. Kurz
KWK. Weber
K. Weber
HBH.-J. Balzer
H.-J. Balzer
KHKatrin Hartmann
Katrin Hartmann

1 July 2005 in Journal of Bone and Mineral Research
Verified
Journal Article
Open access
PDF file
REReinhold G Erben
Reinhold G Erben
DMDagmar Mayer
Dagmar Mayer
KWKarin Weber
Karin Weber
KJKenneth Jonsson
Kenneth Jonsson
HJHarald Jüppner
Harald Jüppner
BLBeate Lanske
Beate Lanske
XLH in humans and the Hyp phenotype in mice are caused by inactivating Phex mutations. Overexpression of human PHEX under the human β‐actin promoter in Hyp mice rescued the bone phenotype almost completely, but did not affect phosphate homeostasis, suggesting that different, possibly independent, pathophysiological mechanisms contribute to hyperphosphaturia and bone abnormalities in XLH. Introduction: Mutations in PHEX, a phosphate‐regulating gene with homologies to endopeptidases on the X chromosome, are responsible for X‐linked hypophosphatemia (XLH) in humans, and its mouse homologs, Hyp, PhexHyp‐2J, PhexHyp‐Duk, Gy and Ska1. PHEX is thought to inactivate a phosphaturic factor, which may be fibroblast growth factor 23 (FGF)‐23. Consistent with this hypothesis, FGF‐23 levels were shown to be elevated in most patients with XLH and in Hyp mice. The aim of this study was, therefore, to examine whether transgenic overexpression of PHEX under the human β‐actin promoter would rescue the Hyp phenotype. Materials and Methods: We tested this hypothesis by generating two mouse lines expressing human PHEX under the control of a human β‐actin promoter (PHEX‐tg). With the exception of brain, RT‐PCR analyses showed transgene expression in all tissues examined. PHEX protein, however, was only detected in bone, muscle, lung, skin, and heart. To assess the role of the mutant PHEX, we crossed female heterozygous Hyp mice with male heterozygous PHEX‐tg mice to obtain wildtype (WT), PHEX‐tg, Hyp, and Hyp/PHEX‐tg offspring, which were examined at 3 months of age. Results: PHEX‐tg mice exhibited normal bone and mineral ion homeostasis. Hyp mice showed the known phenotype with reduced body weight, hypophosphatemia, hyperphosphaturia, and rickets. Hyp/PHEX‐tg mice had almost normal body weight relative to WT controls, showed a dramatic improvement in femoral BMD, almost normal growth plate width, and, despite remaining disturbances in bone mineralization, almost normal bone architecture and pronounced improvements of osteoidosis and of halo formation compared with Hyp mice. However, Hyp and Hyp/PHEX‐tg mice had comparable reductions in tubular reabsorption of phosphate and were hypophosphatemic relative to WT controls. Conclusion: Our data suggest that different, possibly independent, pathophysiological mechanisms contribute to renal phosphate wasting and bone abnormalities in Hyp and XLH.

12 October 2011 in Journal of Veterinary Internal Medicine
Verified
Journal Article
Open access
PDF file
YFY. Fischer
Y. Fischer
SRS. Ritz
S. Ritz
KWK. Weber
K. Weber
CSC. Sauter-Louis
C. Sauter-Louis
KHKatrin Hartmann
Katrin Hartmann
Background Currently there is no drug proven to effectively treat cats with feline infectious peritonitis (FIP). Hypothesis Propentofylline (PPF) can decrease vasculitis, and therefore prolong survival time in cats with FIP, and increase their quality of life. Animals Twenty‐three privately owned cats with FIP. Methods Placebo‐controlled double‐blind trial. FIP was confirmed by histology or immunostaining of feline coronavirus (FCoV) antigen in effusion or tissue macrophages or both. The cats were randomly selected for treatment with either PPF or placebo. All cats received additional treatment with glucocorticoids, antibiotics, and low molecular weight heparin according to methods. Results There was no statistically significant difference in the survival time of cats treated with PPF (8 days, 95% CI 5.4–10.6) versus placebo (7.5 days, 95% CI 4.4–9.6). The median survival time of all cats was 8 days (4–36 days). There was neither a difference in quality of life (day 7, P = .892), in the amount of effusion (day 7, P = .710), the tumor necrosis factor‐alpha (TNF‐α) concentration (day 7, P = .355), nor in any other variable investigated in this study, including a complete blood count, and a small animal biochemistry profile. Conclusions and Clinical Importance This study did not detect an effect of PPF on the survival time, the quality of life, or any clinical or laboratory parameter in cats with FIP. Therefore, PPF does not appear to be an effective treatment option in cats with a late stage of the disease FIP.

1 July 2002 in Molecular Endocrinology
Verified
Journal Article
Open access
PDF file
REReinhold Erben
Reinhold Erben
DSDesi W. Soegiarto
Desi W. Soegiarto
KWKarin Weber
Karin Weber
UZUte Zeitz
Ute Zeitz
MLMichèLe Lieberherr
MichèLe Lieberherr
RBRudi Balling
Rudi Balling
The vitamin D hormone 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3], the biologically active form of vitamin D, is essential for an intact mineral metabolism. Using gene targeting, we sought to generate vitamin D receptor (VDR) null mutant mice carrying the reporter gene lacZ driven by the endogenous VDR promoter. Here we show that our gene-targeted mutant mice express a VDR with an intact hormone binding domain, but lacking the first zinc finger necessary for DNA binding. Expression of the lacZ reporter gene was widely distributed during embryogenesis and postnatally. Strong lacZ expression was found in bones, cartilage, intestine, kidney, skin, brain, heart, and parathyroid glands. Homozygous mice are a phenocopy of mice totally lacking the VDR protein and showed growth retardation, rickets, secondary hyperparathyroidism, and alopecia. Feeding of a diet high in calcium, phosphorus, and lactose normalized blood calcium and serum PTH levels, but revealed a profound renal calcium leak in normocalcemic homozygous mutants. When mice were treated with pharmacological doses of vitamin D metabolites, responses in skin, bone, intestine, parathyroid glands, and kidney were absent in homozygous mice, indicating that the mutant receptor is nonfunctioning and that vitamin D signaling pathways other than those mediated through the classical nuclear receptor are of minor physiological importance. Furthermore, rapid, nongenomic responses to 1,25-(OH)2D3 in osteoblasts were abrogated in homozygous mice, supporting the conclusion that the classical VDR mediates the nongenomic actions of 1,25-(OH)2D3.